Anthem Biosciences Peer Comparison
NSE: ANTHEM | BSE: 544449
₹915.55
₹2.00
(0.22%)
As on 06-Nov-2026IST
Market cap
₹51,539 Cr
Revenue (TTM)
₹2,046 Cr
P/E Ratio
83.9
P/B Ratio
15.7
Div. Yield
0.2 %
Edit
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
51,539 | 2,218 | 90,909 | 62,142 | 57,898 |
Revenue (₹ Cr) |
2,046 | 429 | 9,146 | 6,508 | 9,910 |
Net Profit (₹ Cr) |
613.98 | 80.36 | 1,380.55 | 597.56 | 1,041.67 |
Net Margin (%) |
27.72 | 18.25 | 14.81 | 8.97 | 10.48 |
RoE (%) |
19.97 | 17.20 | 12.87 | 8.35 | 10.54 |
Price to Earnings |
83.94 | 27.61 | 65.85 | 132.02 | 55.76 |
Price-To-Book |
15.71 | 4.51 | 8.02 | 8.35 | 5.53 |
Income Statement (₹ Cr)
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
Operating Revenue
|
2,046.35 | 428.94 | 9,145.79 | 6,508.02 | 9,909.54 |
|
Total Income
|
2,214.87 | 440.23 | 9,320.42 | 6,660.75 | 9,943.40 |
|
Total Expenditure
|
1,199.87 | 280.15 | 6,691.08 | 5,136.46 | 7,711.25 |
|
EBITDA
|
846.48 | 148.79 | 2,454.71 | 1,371.56 | 2,198.29 |
|
Depreciation
|
134.82 | 49.09 | 503.58 | 353.86 | 492.32 |
|
EBIT
|
711.66 | 99.70 | 1,951.13 | 1,017.70 | 1,705.97 |
|
Interest
|
6.45 | 1.10 | 271.17 | 211.64 | 328.76 |
|
Other Income
|
168.53 | 11.30 | 174.63 | 152.73 | 33.86 |
|
Exceptional Items
|
-24.39 | -1.62 | -48.24 | -161.29 | -45.89 |
|
Profit before Tax
|
849.35 | 108.28 | 1,806.35 | 797.50 | 1,365.18 |
|
Provision for Tax
|
235.37 | 27.93 | 425.80 | 199.94 | 323.51 |
|
Profit after Tax
|
613.98 | 80.36 | 1,380.55 | 597.56 | 1,041.67 |
Liabilities (₹ Cr)
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,280.99 | 491.36 | 11,332.03 | 7,790.41 | 10,478.36 |
|
Minority Interest
|
0.00 | 0.00 | 0.02 | -93.19 | -23.51 |
|
Non-Current Liabilities
|
65.03 | 36.82 | 4,696.21 | 6,161.73 | 3,255.22 |
|
Current Liabilities
|
340.37 | 65.08 | 2,492.78 | 2,131.57 | 2,397.33 |
|
Total Liabilities
|
3,633.29 | 562.23 | 17,184.45 | 8,075.76 | 15,832.84 |
Assets (₹ Cr)
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,698.74 | 326.86 | 13,938.16 | 11,434.65 | 11,768.07 |
|
Current Assets
|
1,880.97 | 254.00 | 2,096.26 | 3,620.47 | 1,904.14 |
|
Total Assets
|
3,633.29 | 562.23 | 17,184.45 | 8,075.76 | 15,832.84 |
|
Total Debt*
|
51.07 | 3.33 | 2,906.82 | 701.18 | 2,872.65 |
|
Net Current Assets
|
1,540.60 | 188.92 | -396.52 | 1,488.90 | -493.19 |
|
Contingent Liabilities
|
90.20 | 1.95 | 934.37 | 363.19 | 2,909.60 |
Cashflow (₹ Cr)
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
844.49 | 147.14 | 1,633.32 | 655.92 | 1,601.45 |
|
Cash Flow from Investing Activities
|
-701.62 | -129.67 | -1,688.99 | -288.21 | -1,538.40 |
|
Cash from Financing Activities
|
-40.00 | -10.35 | 59.27 | -304.34 | 163.76 |
|
Net Cash Inflow / Outflow
|
102.87 | 7.12 | 3.60 | 63.37 | 226.81 |
Ratios
Profitability Ratios
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
ROCE (%)
|
29.62 | 24.81 | 14.97 | 16.22 | 14.07 |
|
ROE (%)
|
19.97 | 17.20 | 12.87 | 8.35 | 10.54 |
|
ROA (%)
|
17.62 | 14.46 | 7.89 | 4.72 | 6.63 |
|
EBIT Margin (%)
|
34.78 | 23.24 | 21.33 | 15.64 | 17.22 |
|
Net Margin (%)
|
27.72 | 18.25 | 14.81 | 8.97 | 10.48 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-1.22 | 11.77 | 15.17 | 50.47 | 17.50 |
|
EBIT Growth (%)
|
8.82 | 5.04 | 14.89 | 74.58 | 17.60 |
|
Net Profit Growth (%)
|
18.95 | 7.64 | 1.73 | 50.10 | 1.66 |
|
EPS Growth (%)
|
21.87 | -26.49 | 0.35 | 8.43 | 6.52 |
|
Book Value Growth (%)
|
26.67 | 20.79 | 14.45 | 42.36 | 10.98 |
Valuation Ratios
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
Price / Earnings
|
81.48 | 27.18 | 63.99 | 91.07 | 53.94 |
|
Price / Book Value
|
15.71 | 4.51 | 8.02 | 14.69 | 5.53 |
|
Dividend Yield (%)
|
0.22 | 0.40 | 0.21 | 0.42 | 0.13 |
|
EV/EBITDA
|
59.84 | 14.48 | 37.93 | 44.85 | 27.39 |
|
Market Cap (₹ Cr)
|
36,865.25 | 1,701.05 | 93,580.84 | 34,794.90 | 59,989.09 |
Solvency Ratios
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.01 | 0.02 | 0.23 | 0.44 | 0.19 |
|
Short term debt to equity ratio
|
0.00 | -- | 0.01 | 0.00 | 0.01 |
|
Current Ratio
|
5.53 | 3.90 | 0.84 | 1.70 | 0.79 |
|
Quick Ratio
|
4.97 | 3.45 | 0.79 | 1.60 | 0.73 |
|
Interest Coverage
|
132.70 | 99.44 | 7.66 | 4.77 | 5.15 |
Operating Efficiency Ratios
| Anthem Biosciences | Vimta Labs | Max Healthcare | Aster Dm Health | Fortis Healthcare | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
25.76 | 27.80 | 13.59 | 12.93 | 13.35 |
|
Asset Turnover
|
0.59 | 0.77 | 0.52 | 0.51 | 0.63 |
|
Receivable days
|
87.02 | 94.97 | 36.12 | 22.21 | 36.55 |
|
Inventory Days
|
38.87 | 24.65 | 4.81 | 7.21 | 5.01 |
|
Payable days
|
41.63 | -- | 169.18 | 157.95 | 152.97 |
|
Cash Conversion Cycle
|
84.26 | -- | -128.26 | -128.53 | -111.41 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
